CATX logo

Perspective Therapeutics (CATX)

Profile

Full Name

Perspective Therapeutics, Inc.

Ticker Symbol

CATX

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

November 10, 2005

Indexes

Not included

Website

http://www.perspectivetherapeutics.com

Employees

138

Key Details

Price

$1.85(-11.48%)

Market cap

$137.00M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.23(+29.31% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.85
CATX price is $1.85

30-Day Relative Volume

0.92
CATX 30-day relative volume is 0.92

Price Performance

Price Today change

-11.48%
CATX price is down -11.48% today

Price YTD change

-42.01%
CATX price is down -42.01% since January 1st

Price 1-year change

-87.33%
CATX price is down -87.33% year-on-year

Price 3-year change

-45.59%
CATX price is down -45.59% over the past 3 years

Price Range

Price All-time high

$4804.80
CATX price is currently -99.96% below its historical high of $4804.80

Price 3-year low

$0.19
CATX price is currently +873.68% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$137.00M
CATX market capitalization is $137.00 million

Market cap 3-year change

+183.67%
CATX market capitalization is up +183.67% over the past 3 years

Market cap All-time high

$1.10B
CATX market capitalization is currently -87.50% below its historical high of $1.10 billion

Market cap sector rank

52.47%
CATX market capitalization is higher than 52.47% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+26.17%
CATX shares outstanding is up +26.17% year-on-year

Shares Outstanding 3-Year Change

+421.34%
CATX shares outstanding is up +421.34% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.44
CATX beta is 1.44

200-day SMA

$7.88
CATX price is currently -76.53% below its 200-day simple moving average

50-day SMA

$2.51
CATX price is currently -26.36% below its 50-day simple moving average

RSI

37.34
CATX 14-day relative strength index is 37.34

Volume

0.92
CATX 30-day relative volume is 0.92

ATR

$0.21
CATX average true range is $0.21

10-day Historical Volatility

108.79%
CATX 10-day historical volatility is 108.79%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CATX annual revenue value is unknown

Revenue Analysts estimate

$11.18M
CATX annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CATX annual revenue 1-year change is unknown

Revenue Sector rank

-
CATX annual revenue is unknown

EPS

EPS

-$1.23
CATX annual earnings per share is -$1.23

EPS Analysts estimate

-
CATX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+29.31%
CATX annual earnings per share is up +29.31% year-on-year

EPS Sector rank

51.45%
CATX annual earnings per share is higher than 51.45% of companies in Healthcare sector

Profit

Gross profit

-
CATX annual gross profit value is unknown

Gross margin

-
CATX annual gross profit margin value is unknown

Operating profit

-$66.80M
CATX annual operating income is -$66.80 million

Operating margin

-
CATX annual operating profit margin value is unknown

Net income

-$79.28M
CATX annual net profit is -$79.28 million

Net margin

-
CATX annual net profit margin value is unknown

Expenses

Total expenses

$66.80M
CATX annual total expenses is $66.80 million

Operating expenses

$66.80M
CATX annual total operating expenses is $66.80 million

Cost of goods sold

-
CATX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$26.61M
CATX annual SGA is $26.61 million

Depreciation and amortization

$2.31M
CATX annual depreciation & amortization is $2.31 million

Interest expense

$48.00K
CATX annual interest expense is $48.00 thousand

Income tax

-$2.10M
CATX annual income tax is -$2.10 million

EBIT & EBITDA

EBIT

-$80.38M
CATX annual earnings before interest & taxes is -$80.38 million

EBITDA

-$78.07M
CATX annual EBITDA is -$78.07 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$341.10M
CATX annual total assets is $341.10 million

Non current assets

$109.94M
CATX annual long term assets is $109.94 million

Current assets

$231.16M
CATX annual total current assets is $231.16 million

Cash and cash equivalents

$61.58M
CATX annual cash & cash equivalents is $61.58 million

Accounts receivable

$116.00K
CATX annual accounts receivable is $116.00 thousand

Inventory

-
CATX annual inventory value is unknown

Liabilities

Total liabilities

$50.43M
CATX annual total liabilities is $50.43 million

Long term liabilities

$32.20M
CATX annual total long term liabilities is $32.20 million

Current liabilities

$18.23M
CATX annual total current liabilities is $18.23 million

Accounts payable

$10.34M
CATX annual accounts payable is $10.34 million

Debt

Total debt

$4.06M
CATX annual total debt is $4.06 million

Total debt 1-year change

+59.23%
CATX annual total debt is up +59.23% year-on-year

Long term debt

$3.05M
CATX annual long term debt is $3.05 million

Short term debt

$1.01M
CATX annual short term debt is $1.01 million

Equity & Capital

Shareholders equity

$290.67M
CATX annual stockholders equity is $290.67 million

Book value

$290.67M
CATX annual book value is $290.67 million

Retained earnings

-$231.72M
CATX annual retained earnings is -$231.72 million

Working capital

$212.93M
CATX annual working capital is $212.93 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$18.29M
CATX annual cash flow from operations is -$18.29 million

Cash from operations 1-year change

+50.44%
CATX annual cash flow from operations is up +50.44% year-on-year

Cash from investing

-$218.93M
CATX annual cash flow from investing activities is -$218.93 million

Cash from investing 1-year change

-998.25%
CATX annual cash flow from investing activities is down -998.25% year-on-year

Cash from financing

$289.38M
CATX annual cash flow from financing activities is $289.38 million

Cash from financing 1-year change

+36764.33%
CATX annual cash flow from financing activities is up +36764.33% year-on-year

CAPEX

CAPEX

-
CATX annual capital expenditures value is unknown

CAPEX 1-year change

-
CATX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$72.71M
CATX annual free cash flow is -$72.71 million

Free cash flow 1-year change

-91.41%
CATX annual free cash flow is down -91.41% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CATX annual gross profit margin value is unknown

Operating margin

-
CATX annual operating profit margin value is unknown

Net margin

-
CATX annual net profit margin value is unknown

ROA & ROE

ROA

-23.24%
CATX annual return on assets is -23.24%

ROE

-27.27%
CATX annual return on equity is -27.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CATX price to earnings ratio value is unknown

PE ratio Sector rank

-
CATX price to earnings ratio is unknown

PB Ratio

PB ratio

0.47
CATX price to book ratio is 0.47

PB ratio Sector rank

28.97%
CATX price to book ratio is higher than 28.97% of companies in Healthcare sector

PS Ratio

PS ratio

-
CATX price to sales ratio value is unknown

PS ratio Sector rank

-
CATX price to sales ratio is unknown

Enterprise value

Enterprise value

$79.48M
CATX enterprise value is $79.48 million

Enterprise value Sector rank

46.98%
CATX enterprise value is higher than 46.98% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.02
CATX EV/EBITDA is -1.02

EV/EBITDA Sector rank

42.21%
CATX EV/EBITDA is higher than 42.21% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.68
CATX annual current ratio is 12.68

Quick ratio

-
CATX annual quick ratio value is unknown

Leverage

Debt to equity

0.01
CATX annual debt to equity ratio is 0.01

Interest coverage ratio

-1674.56
CATX annual interest coverage ratio is -1674.56

Risk & Stability

Piotroski F-Score

-
CATX piotroski f-score value is unknown

Altman Z-Score

-
CATX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 7, 25 Truist Securities
Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Mar 27, 25 Wedbush
Outperform
Mar 27, 25 RBC Capital
Outperform
Mar 19, 25 HC Wainwright & Co.
Buy
Mar 13, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Scotiabank
Sector Outperform
Jan 14, 25 RBC Capital
Outperform
Nov 25, 24 RBC Capital
Outperform
Nov 25, 24 B of A Securities
Neutral

Institutional Ownership

Similar stocks

Actuate Therapeutics (ACTU)
ARAY logo
Accuray Incorporated (ARAY)
MYO logo
Myomo (MYO)
OPRX logo
OptimizeRx (OPRX)
TARA logo
Protara Therapeutics (TARA)
JYNT logo
Joint (JYNT)
BWAY logo
BrainsWay (BWAY)
MASS logo
908 Devices (MASS)
STXS logo
Stereotaxis (STXS)
  • What is the ticker symbol for Perspective Therapeutics?
  • Does Perspective Therapeutics pay dividends?
  • What sector is Perspective Therapeutics in?
  • What industry is Perspective Therapeutics in?
  • What country is Perspective Therapeutics based in?
  • When did Perspective Therapeutics go public?
  • Is Perspective Therapeutics in the S&P 500?
  • Is Perspective Therapeutics in the NASDAQ 100?
  • Is Perspective Therapeutics in the Dow Jones?
  • When was Perspective Therapeutics's last earnings report?
  • When does Perspective Therapeutics report earnings?
  • Should I buy Perspective Therapeutics stock now?

What is the ticker symbol for Perspective Therapeutics?

The ticker symbol for Perspective Therapeutics is NYSE American:CATX

Does Perspective Therapeutics pay dividends?

No, Perspective Therapeutics does not pay dividends

What sector is Perspective Therapeutics in?

Perspective Therapeutics is in the Healthcare sector

What industry is Perspective Therapeutics in?

Perspective Therapeutics is in the Medical Devices industry

What country is Perspective Therapeutics based in?

Perspective Therapeutics is headquartered in United States

When did Perspective Therapeutics go public?

Perspective Therapeutics's initial public offering (IPO) was on November 10, 2005

Is Perspective Therapeutics in the S&P 500?

No, Perspective Therapeutics is not included in the S&P 500 index

Is Perspective Therapeutics in the NASDAQ 100?

No, Perspective Therapeutics is not included in the NASDAQ 100 index

Is Perspective Therapeutics in the Dow Jones?

No, Perspective Therapeutics is not included in the Dow Jones index

When was Perspective Therapeutics's last earnings report?

Perspective Therapeutics's most recent earnings report was on Mar 26, 2025

When does Perspective Therapeutics report earnings?

The next expected earnings date for Perspective Therapeutics is May 15, 2025

Should I buy Perspective Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page